MAP PHARMACEUTICALS, INC. Additional Paid in Capital
MAP PHARMACEUTICALS, INC. had Additional Paid in Capital of $374.93 million as of 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2012-11-06
- 2012-09-30: Additional Paid in Capital $374.93M.
- 2012-06-30: Additional Paid in Capital $316.95M.
- 2012-03-31: Additional Paid in Capital $314.24M.
- 2011-12-31: Additional Paid in Capital $311.75M.
| Period end | Additional Paid in Capital |
|---|---|
| 2012-09-30 | $374.93M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $316.95M 10-Q · filed 2012-07-27 |
| 2012-03-31 | $314.24M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $311.75M 10-Q · filed 2012-11-06 |
| 2011-09-30 | $309.19M 10-Q/A · filed 2012-03-30 |
| 2011-06-30 | $307.45M 10-Q/A · filed 2012-03-30 |
| 2010-12-31 | $301.92M 10-K · filed 2012-03-30 |